No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:74619400-74632200 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
2 |
chr5:74621000-74632200 |
Weak transcription |
Sigmoid Colon |
Sigmoid Colon
|
3 |
chr5:74626000-74631800 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
4 |
chr5:74627800-74631600 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
5 |
chr5:74628000-74631800 |
Weak transcription |
Duodenum Mucosa |
Duodenum
|
6 |
chr5:74628400-74632000 |
Weak transcription |
Stomach Mucosa |
stomach
|
7 |
chr5:74629200-74631600 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
8 |
chr5:74629400-74631800 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
9 |
chr5:74630400-74631600 |
Weak transcription |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
10 |
chr5:74631000-74632000 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
11 |
chr5:74631200-74631600 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
12 |
chr5:74631200-74631800 |
Enhancers |
iPS-20b Cell Line |
embryonic stem cell
|
13 |
chr5:74631200-74631800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
14 |
chr5:74631200-74631800 |
Enhancers |
Dnd41 |
blood
|
15 |
chr5:74631200-74632000 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
16 |
chr5:74631200-74632000 |
Enhancers |
Fetal Intestine Small |
intestine
|
17 |
chr5:74631400-74631600 |
Enhancers |
Small Intestine |
intestine
|
18 |
chr5:74631400-74631600 |
Flanking Active TSS |
HepG2 |
liver
|
19 |
chr5:74631400-74631800 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
20 |
chr5:74631400-74631800 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
21 |
chr5:74631400-74631800 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
22 |
chr5:74631400-74631800 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
23 |
chr5:74631400-74631800 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
24 |
chr5:74631400-74631800 |
Enhancers |
HUES48 Cell Line |
embryonic stem cell
|
25 |
chr5:74631400-74631800 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
26 |
chr5:74631400-74631800 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
27 |
chr5:74631400-74631800 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
28 |
chr5:74631400-74631800 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
29 |
chr5:74631400-74631800 |
Weak transcription |
A549 |
lung
|
30 |
chr5:74631400-74631800 |
Enhancers |
HMEC |
breast
|
31 |
chr5:74631400-74631800 |
Enhancers |
NHEK |
skin
|
32 |
chr5:74631400-74631800 |
Enhancers |
NHLF |
lung
|
33 |
chr5:74631400-74632000 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
34 |
chr5:74631400-74632000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
35 |
chr5:74631400-74632000 |
Enhancers |
Liver |
Liver
|
36 |
chr5:74631400-74632000 |
Enhancers |
Hela-S3 |
cervix
|
37 |
chr5:74631400-74632400 |
Flanking Active TSS |
K562 |
blood
|